Physician profile
John F Cabrera
NPI 1992798730
$549.81
in general payments reported to CMS, 2019-2025
9 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.95 · 2021: $43.92 · 2023: $22.87 · 2024: $143 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $179.00 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $94.32 | 2019-2025 | |
| Shield Therapeutics INC | $79.82 | 2024-2025 | |
| Astellas Pharma US INC | $76.05 | 2024 | Veozah |
| Aspira Women'S Health INC | $44.13 | 2021-2023 | Ova1 |
| Sumitomo Pharma America, INC. | $24.56 | 2025 | Gemtesa |
| Supernus Pharmaceuticals, INC. | $21.95 | 2025 | Qelbree |
| Meditrina | $17.03 | 2025 | |
| Lupin INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.